SCHEMBL7722056

SCHEMBL7722056

CC(C)(C)OC(=O)N1CC[C@@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@@H]1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HSD11B1 P28845 2/20 0.35
KLK7 P49862 1/20 0.35
AGTR2 P50052 3/20 0.34
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7722230 1.00 HSD17B10 (0.40) HSD17B10SMN1; SMN2HSD11B1KLK7AGTR2
SCHEMBL7729134 0.90 PTPN1 (0.38) HSD17B10SMN1; SMN2HSD11B1AGTR2MEN1
SCHEMBL7729049 0.90 PTPN1 (0.38) HSD17B10SMN1; SMN2HSD11B1AGTR2MEN1
SCHEMBL7727961 0.88 HSD17B10 (0.34) HSD17B10SMN1; SMN2HSD11B1AGTR2NFKB1
SCHEMBL7728185 0.88 HSD17B10 (0.34) HSD17B10SMN1; SMN2HSD11B1AGTR2NFKB1
SCHEMBL7726101 0.88 HSD17B10 (0.34) HSD17B10SMN1; SMN2HSD11B1AGTR2NFKB1
SCHEMBL7733813 0.78 PTPN1 (0.39) SMN1; SMN2HSD11B1NFKB1NFKB2RELA
SCHEMBL7726393 0.78 PTPN1 (0.39) SMN1; SMN2HSD11B1NFKB1NFKB2RELA
SCHEMBL7733526 0.78 PTPN1 (0.39) SMN1; SMN2HSD11B1NFKB1NFKB2RELA
SCHEMBL7730860 0.76 NFKB1 (0.34) HSD17B10HSD11B1NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed